Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy

Area of Science:

• Immunology
• Nephrology
• Autoimmune Diseases

Background:

• IgA nephropathy (IgAN) is defined by immunoglobulin A (IgA) deposition in the kidneys.
• The origin of this deposited IgA remains unclear, with both mucosal and systemic IgA systems potentially involved.

Purpose of the Study:

• To investigate mucosal and systemic antibody production in IgA nephropathy patients following a systemic antigen challenge.
• To explore the relationship between the mucosal and systemic IgA systems in IgAN.

Main Methods:

• 20 IgA nephropathy patients and 20 controls were immunized with tetanus toxoid (TT).
• Serum and salivary antibody responses were measured.
• In vitro IgA production by Epstein-Barr virus (EBV)-transformed peripheral blood lymphocytes (PBLs) was assessed.

Main Results:

• IgA nephropathy patients produced a higher ratio of IgA1 to IgA2 antibodies compared to controls.
• Unlike controls, IgA nephropathy patients exhibited a significant salivary IgA response to TT.
• Patients with IgAN showed increased and prolonged in vitro IgA anti-TT production from PBLs post-immunization.

Conclusions:

• Systemic immunization in IgA nephropathy leads to heightened IgA antibody production in both systemic and mucosal compartments.
• These findings suggest an abnormal interplay between the mucosal and systemic IgA systems in IgAN patients.
• The study highlights a potential mechanism contributing to IgA deposition in the kidneys.